Urine was also collected in in vivo99mTc biodistribution experiments (from male SCID/Beige mice bearing DU145-PSMA+ prostate cancer xenografts at 2 h post-injection) and analysed using reverse-phase radio-HPLC (Fig. 3). This evidence concerns the gene FOLH1 and prostate cancer.